VA OKs payment for Alzheimer's drug Leqembi

The Department of Veterans Affairs announced it will cover Leqembi, the Alzheimer's drug manufactured by Eisai  and Biogen, which received accelerated approval from the FDA in January, according to a March 13 company news release.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive